Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500111684Phase 4Not yet recruiting
Phase 4, randomised trial in colon cancer and rectal cancer comparing Sevoflurane + remifentanil anesthesia with Remimazolam + remifentanil anesthesia (2 arms). Primary endpoint: QoR-15 score at 24 hours postoperatively. Planned start Nov 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500111684.